deferasirox has been researched along with Disease, Pulmonary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brass, EP; Chin-Hong, PV; Fredricks, D; Ibrahim, AS; Kontoyiannis, DP; Morris, MI; Perfect, JR; Spellberg, B | 1 |
1 trial(s) available for deferasirox and Disease, Pulmonary
| Article | Year |
|---|---|
Risk factors for mortality in patients with mucormycosis.
Topics: Adult; Aged; Amphotericin B; Benzoates; Deferasirox; Double-Blind Method; Ferritins; Humans; Iron; Kaplan-Meier Estimate; Lung Diseases; Middle Aged; Mucor; Mucormycosis; Risk Factors; Time Factors; Treatment Outcome; Triazoles | 2012 |